Tiffany Suzanne Davies, MD
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Davies’s office at (408) 378-1101 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$42,026
Medicare paid this office $42,026 for 106 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 49 | $8,725 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $8,038 | $158 |
| Short return visit (20+ min) | 65 | $7,677 | $75 |
| Sarscv2 vac 30mcg trs-suc im | 28 | $4,205 | $150 |
| Influenza vaccine split virus, preservative free | 34 | $2,762 | $81 |
See all 9 services
| Return visit (30+ min) | 49 | $8,725 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $8,038 | $158 |
| Short return visit (20+ min) | 65 | $7,677 | $75 |
| Sarscv2 vac 30mcg trs-suc im | 28 | $4,205 | $150 |
| Influenza vaccine split virus, preservative free | 34 | $2,762 | $81 |
| Admn sarscov2 vacc 1 dose | 28 | $1,459 | $52 |
| Administration of influenza virus vaccine | 34 | $1,328 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 49 | $1,060 | $13 |
| Annual depression screening, 5 to 15 minutes | 26 | $633 | $24 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
106 Original Medicare patients in 2024. Average age 76 · Women 79% · Also on Medicaid 0% · Health risk score 0.92. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 61% · Cancer 18% · Coronary heart disease 16% · Depression 15% · Atrial fibrillation 13% · Diabetes 12% · Chronic kidney disease 10%.
The office billed $101,612, Medicare allowed $52,403 and paid $42,026; for 526 services of 30 kinds; $8,419 of it was for drugs given in the office and $33,607 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 106 | 526 | 76 | 0.92 | $101,612 | $42,026 |
| 2023 | 104 | 431 | 76 | 0.89 | $99,703 | $40,118 |
| 2022 | 106 | 436 | 75 | 0.82 | $75,578 | $36,833 |
| 2021 | 160 | 509 | 74 | 0.71 | $84,384 | $39,717 |
| 2020 | 163 | 459 | 74 | 0.75 | $93,975 | $30,399 |
| 2019 | 140 | 507 | 73 | 0.70 | $96,933 | $33,996 |
| 2018 | 138 | 487 | 74 | 0.67 | $91,626 | $31,444 |
| 2017 | 133 | 470 | 74 | 0.68 | $93,418 | $34,041 |
| 2016 | 142 | 488 | 73 | 0.74 | $72,606 | $32,964 |
| 2015 | 128 | 524 | 72 | 0.60 | $59,012 | $39,313 |
| 2014 | 110 | 367 | 72 | 0.64 | $39,232 | $24,044 |
| 2013 | 118 | 351 | 72 | 0.62 | $36,810 | $22,565 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 60 | $9,354 | $156 |
| Short return visit (20+ min) | 71 | $7,582 | $68 |
| Return visit (30+ min) | 39 | $6,828 | $108 |
| Influenza vaccine split virus, preservative free | 35 | $2,518 | $72 |
| Sarscv2 vac 30mcg trs-suc im | 18 | $2,313 | $128 |
| Administration of influenza virus vaccine | 38 | $1,404 | $37 |
| Admn sarscov2 vacc 1 dose | 18 | $887 | $49 |
| Annual depression screening, 5 to 15 minutes | 11 | $259 | $24 |
2022: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $9,230 | $151 |
| Short return visit (20+ min) | 70 | $8,483 | $69 |
| Return visit (30+ min) | 46 | $6,665 | $89 |
| Influenza vaccine split virus, preservative free | 41 | $2,810 | $69 |
| Administration of influenza virus vaccine | 43 | $1,601 | $37 |
| Administration of pneumococcal vaccine | 11 | $451 | $38 |
2021: 7 services
| Short return visit (20+ min) | 112 | $12,374 | $66 |
| Return visit (30+ min) | 63 | $9,735 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 57 | $8,583 | $151 |
| Influenza vaccine split virus, preservative free | 40 | $2,610 | $65 |
| Administration of influenza virus vaccine | 39 | $843 | $22 |
| Destruction of precancer skin growth, 1 growth | 11 | $670 | $48 |
| Urinalysis, manual test | 15 | $52 | $3 |
2020: 7 services
| Short return visit (20+ min) | 131 | $12,909 | $62 |
| Return visit (30+ min) | 59 | $7,802 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,666 | $140 |
| Influenza vaccine split virus, preservative free | 30 | $1,890 | $61 |
| Administration of influenza virus vaccine | 35 | $733 | $21 |
| Short return visit | 12 | $543 | $39 |
| Urinalysis, manual test | 13 | $52 | $3 |
2019: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 69 | $9,608 | $139 |
| Short return visit (20+ min) | 91 | $8,084 | $61 |
| Return visit (30+ min) | 36 | $4,405 | $86 |
| Influenza vaccine split virus, preservative free | 36 | $1,973 | $55 |
| Annual depression screening, 5 to 15 minutes | 56 | $1,252 | $22 |
| Administration of influenza virus vaccine | 40 | $841 | $21 |
| Short return visit | 13 | $570 | $44 |
| Administration of pneumococcal vaccine | 14 | $287 | $21 |
2018: 8 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $8,441 | $136 |
| Short return visit (20+ min) | 82 | $6,741 | $55 |
| Return visit (30+ min) | 43 | $4,469 | $81 |
| Influenza vaccine split virus, preservative free | 33 | $1,726 | $52 |
| Annual depression screening, 5 to 15 minutes | 52 | $1,125 | $22 |
| Administration of influenza virus vaccine | 42 | $1,106 | $26 |
| Administration of pneumococcal vaccine | 13 | $360 | $26 |
| Urinalysis, manual test | 16 | $72 | $3 |
2017: 9 services
| Short return visit (20+ min) | 89 | $8,032 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 57 | $7,896 | $139 |
| Return visit (30+ min) | 39 | $4,678 | $92 |
| Pneumococcal vaccine, 13-valent | 14 | $2,575 | $184 |
| Influenza vaccine split virus, preservative free | 38 | $1,826 | $48 |
| Administration of influenza virus vaccine | 37 | $1,195 | $32 |
| Administration of pneumococcal vaccine | 23 | $743 | $32 |
| Annual depression screening, 5 to 15 minutes | 29 | $645 | $22 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $597 | $46 |
2016: 8 services
| Short return visit (20+ min) | 80 | $7,083 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 52 | $7,015 | $135 |
| Return visit (30+ min) | 51 | $5,228 | $86 |
| Pneumococcal vaccine, 13-valent | 21 | $3,711 | $177 |
| Influenza vaccine split virus, preservative free | 47 | $1,880 | $40 |
| Administration of influenza virus vaccine | 50 | $1,584 | $32 |
| Administration of pneumococcal vaccine | 24 | $760 | $32 |
| Annual depression screening, 5 to 15 minutes | 26 | $564 | $22 |
2015: 8 services
| Pneumococcal vaccine, 13-valent | 72 | $11,615 | $161 |
| Short return visit (20+ min) | 88 | $7,638 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 52 | $7,044 | $135 |
| Return visit (30+ min) | 29 | $3,442 | $80 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $2,375 | $198 |
| Administration of pneumococcal vaccine | 70 | $2,219 | $32 |
| Administration of influenza virus vaccine | 31 | $1,017 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 17 | $264 | $16 |
2014: 7 services
| Short return visit (20+ min) | 81 | $7,126 | $55 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $4,755 | $132 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 18 | $3,498 | $194 |
| Return visit (30+ min) | 27 | $2,796 | $80 |
| Administration of influenza virus vaccine | 24 | $747 | $31 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 15 | $660 | $44 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 16 | $186 | $12 |
2013: 7 services
| Short return visit (20+ min) | 91 | $7,617 | $55 |
| Return visit (30+ min) | 34 | $3,633 | $87 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 16 | $3,171 | $198 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,405 | $134 |
| Long return visit (40+ min) | 12 | $1,593 | $133 |
| Administration of influenza virus vaccine | 26 | $835 | $32 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 28 | $250 | $9 |
Drugs they prescribed that Part D paid
$66,432
Pharmacies billed $66,432 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
753 generic and fewer than 11 brand-name prescriptions · $66,432 in drug cost · 39 antibiotic prescriptions to 24 people · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trulicity | 12 | $11,526 | $960 |
| Raloxifene | 13 | $1,825 | $140 |
| Rosuvastatin | 41 | $1,670 | $41 |
| Gabapentin | 30 | $1,198 | $40 |
| Atorvastatin | 72 | $924 | $13 |
See all 27 drugs
| Trulicity | 12 | $11,526 | $960 |
| Raloxifene | 13 | $1,825 | $140 |
| Rosuvastatin | 41 | $1,670 | $41 |
| Gabapentin | 30 | $1,198 | $40 |
| Atorvastatin | 72 | $924 | $13 |
| Synthroid | 13 | $808 | $62 |
| Estradiol | 15 | $732 | $49 |
| Levothyroxine | 58 | $667 | $12 |
| Estradiol (Once Weekly) | 11 | $655 | $60 |
| Escitalopram | 23 | $597 | $26 |
| Olmesartan Medoxomil | 12 | $447 | $37 |
| Metoprolol | 18 | $394 | $22 |
| Donepezil | 17 | $378 | $22 |
| Chlorthalidone | 15 | $361 | $24 |
| Bupropion Xl | 12 | $312 | $26 |
| Losartan | 27 | $302 | $11 |
| Lisinopril | 35 | $260 | $7 |
| Risperidone | 13 | $238 | $18 |
| Amlodipine Besylate | 25 | $235 | $9 |
| Simvastatin | 17 | $205 | $12 |
| Zolpidem | 14 | $197 | $14 |
| Valsartan | 13 | $173 | $13 |
| Cephalexin | 13 | $168 | $13 |
| Lamotrigine | 13 | $67 | $5 |
| Hydrochlorothiazide | 18 | $50 | $3 |
| Furosemide | 12 | $50 | $4 |
| Sertraline | 11 | $41 | $4 |
Year by year
| 2024 | 866 | 90 | None | None | $66,432 |
| 2023 | 875 | 83 | None | None | $76,455 |
| 2022 | 827 | 128 | None | 17% | $77,056 |
| 2021 | 839 | 125 | None | 13% | $60,299 |
| 2020 | 831 | 114 | 1% (12) | 16% | $56,310 |
| 2019 | 819 | 103 | None | None | $59,228 |
| 2018 | 848 | 111 | None | None | $61,491 |
| 2017 | 713 | 104 | None | None | $38,757 |
| 2016 | 733 | 104 | None | 15% | $41,511 |
| 2015 | 650 | 82 | None | 23% | $38,497 |
| 2014 | 635 | 78 | None | 23% | $42,400 |
| 2013 | 606 | 76 | None | None | $39,653 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Trulicity | 13 | $13,584 | $1,045 |
| Trelegy Ellipta | 14 | $7,964 | $569 |
| Rosuvastatin | 24 | $1,783 | $74 |
| Levothyroxine | 68 | $1,171 | $17 |
| Metoprolol | 44 | $1,004 | $23 |
| Olmesartan Medoxomil | 11 | $672 | $61 |
| Atorvastatin | 52 | $660 | $13 |
| Bupropion Xl | 15 | $551 | $37 |
| Escitalopram | 31 | $486 | $16 |
| Diltiazem 24hr Er (Cd) | 11 | $434 | $39 |
| Chlorthalidone | 22 | $411 | $19 |
| Cephalexin | 15 | $373 | $25 |
| Simvastatin | 21 | $312 | $15 |
| Lisinopril | 39 | $303 | $8 |
| Losartan | 39 | $271 | $7 |
| Gabapentin | 14 | $255 | $18 |
| Donepezil | 12 | $250 | $21 |
| Losartan-Hydrochlorothiazide | 11 | $249 | $23 |
| Pantoprazole | 17 | $225 | $13 |
| Zolpidem | 11 | $215 | $20 |
| Amlodipine Besylate | 19 | $213 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $131 | $12 |
| Hydrochlorothiazide | 15 | $116 | $8 |
| Sertraline | 12 | $115 | $10 |
| Ropinirole | 11 | $114 | $10 |
| Furosemide | 21 | $110 | $5 |
| Famotidine | 19 | $89 | $5 |
| Lamotrigine | 11 | $53 | $5 |
2022: 19 drugs
| Dexilant | 12 | $3,914 | $326 |
| Rosuvastatin | 12 | $1,508 | $126 |
| Atorvastatin | 72 | $1,261 | $18 |
| Levothyroxine | 59 | $972 | $16 |
| Metoprolol | 40 | $940 | $24 |
| Simvastatin | 41 | $537 | $13 |
| Potassium Chloride | 16 | $456 | $28 |
| Chlorthalidone | 21 | $397 | $19 |
| Escitalopram | 22 | $306 | $14 |
| Losartan | 21 | $285 | $14 |
| Lisinopril | 34 | $266 | $8 |
| Diltiazem 24hr Er (Cd) | 11 | $167 | $15 |
| Tamsulosin | 11 | $161 | $15 |
| Paxlovid (Eua) | 17 | $161 | $9 |
| Metformin | 16 | $135 | $8 |
| Amlodipine Besylate | 18 | $126 | $7 |
| Hydrochlorothiazide | 19 | $124 | $7 |
| Zolpidem | 15 | $96 | $6 |
| Furosemide | 15 | $53 | $4 |
2021: 20 drugs
| Dexilant | 11 | $3,316 | $301 |
| Valsartan-Hydrochlorothiazide | 14 | $1,453 | $104 |
| Levothyroxine | 69 | $1,347 | $20 |
| Metoprolol | 29 | $921 | $32 |
| Simvastatin | 64 | $883 | $14 |
| Atorvastatin | 56 | $661 | $12 |
| Synthroid | 14 | $641 | $46 |
| Losartan | 24 | $513 | $21 |
| Olmesartan Medoxomil | 12 | $420 | $35 |
| Alendronate | 15 | $284 | $19 |
| Lisinopril | 34 | $234 | $7 |
| Metformin | 17 | $178 | $10 |
| Hydrochlorothiazide | 31 | $171 | $6 |
| Sertraline | 14 | $166 | $12 |
| Amlodipine Besylate | 17 | $138 | $8 |
| Lisinopril-Hydrochlorothiazide | 17 | $121 | $7 |
| Zolpidem | 13 | $117 | $9 |
| Ciprofloxacin | 11 | $72 | $7 |
| Alprazolam | 12 | $40 | $3 |
| Lorazepam | 15 | $17 | $1 |
2020: 20 drugs
| Dexilant | 11 | $3,129 | $284 |
| Levothyroxine | 65 | $1,560 | $24 |
| Valsartan-Hydrochlorothiazide | 13 | $1,337 | $103 |
| Atorvastatin | 63 | $1,298 | $21 |
| Celecoxib | 11 | $1,017 | $92 |
| Simvastatin | 64 | $850 | $13 |
| Metoprolol | 25 | $741 | $30 |
| Losartan | 30 | $626 | $21 |
| Synthroid | 14 | $567 | $40 |
| Duloxetine | 12 | $364 | $30 |
| Paroxetine | 14 | $300 | $21 |
| Lisinopril | 36 | $289 | $8 |
| Pravastatin | 11 | $263 | $24 |
| Amlodipine Besylate | 18 | $231 | $13 |
| Metformin | 17 | $219 | $13 |
| Hydrochlorothiazide | 20 | $152 | $8 |
| Lisinopril-Hydrochlorothiazide | 16 | $146 | $9 |
| Nitrofurantoin Mono-Macro | 12 | $143 | $12 |
| Alendronate | 11 | $111 | $10 |
| Clonazepam | 12 | $104 | $9 |
2019: 18 drugs
| Atorvastatin | 74 | $1,625 | $22 |
| Levothyroxine | 66 | $1,424 | $22 |
| Simvastatin | 76 | $868 | $11 |
| Synthroid | 15 | $778 | $52 |
| Valsartan-Hydrochlorothiazide | 11 | $704 | $64 |
| Metoprolol | 18 | $591 | $33 |
| Gabapentin | 16 | $461 | $29 |
| Losartan | 24 | $376 | $16 |
| Paroxetine | 14 | $343 | $24 |
| Lisinopril | 29 | $316 | $11 |
| Duloxetine | 17 | $282 | $17 |
| Losartan-Hydrochlorothiazide | 11 | $259 | $24 |
| Metformin | 21 | $172 | $8 |
| Nitrofurantoin Mono-Macro | 11 | $165 | $15 |
| Lisinopril-Hydrochlorothiazide | 18 | $160 | $9 |
| Hydrochlorothiazide | 18 | $142 | $8 |
| Tamsulosin | 13 | $122 | $9 |
| Clonazepam | 15 | $115 | $8 |
2018: 17 drugs
| Eliquis | 12 | $5,083 | $424 |
| Atorvastatin | 85 | $2,009 | $24 |
| Levothyroxine | 59 | $1,410 | $24 |
| Simvastatin | 74 | $1,045 | $14 |
| Metoprolol | 20 | $917 | $46 |
| Synthroid | 16 | $651 | $41 |
| Valsartan-Hydrochlorothiazide | 13 | $487 | $37 |
| Losartan | 27 | $332 | $12 |
| Losartan-Hydrochlorothiazide | 15 | $312 | $21 |
| Lisinopril | 32 | $283 | $9 |
| Gabapentin | 11 | $260 | $24 |
| Amlodipine Besylate | 11 | $227 | $21 |
| Hydrochlorothiazide | 23 | $218 | $9 |
| Lisinopril-Hydrochlorothiazide | 20 | $210 | $11 |
| Zolpidem | 23 | $168 | $7 |
| Clonazepam | 13 | $146 | $11 |
| Metformin | 16 | $123 | $8 |
2017: 13 drugs
| Advair Diskus | 11 | $3,237 | $294 |
| Levothyroxine | 56 | $1,778 | $32 |
| Atorvastatin | 68 | $1,461 | $21 |
| Metoprolol | 31 | $1,035 | $33 |
| Simvastatin | 61 | $686 | $11 |
| Amlodipine Besylate | 25 | $343 | $14 |
| Losartan | 30 | $327 | $11 |
| Hydrochlorothiazide | 29 | $299 | $10 |
| Synthroid | 11 | $235 | $21 |
| Lisinopril-Hydrochlorothiazide | 22 | $223 | $10 |
| Lisinopril | 25 | $217 | $9 |
| Zolpidem | 17 | $203 | $12 |
| Alendronate | 13 | $89 | $7 |
2016: 13 drugs
| Levothyroxine | 55 | $1,664 | $30 |
| Atorvastatin | 62 | $1,432 | $23 |
| Simvastatin | 81 | $1,175 | $15 |
| Metoprolol | 21 | $841 | $40 |
| Zolpidem | 13 | $424 | $33 |
| Hydrochlorothiazide | 31 | $340 | $11 |
| Losartan | 24 | $339 | $14 |
| Lisinopril-Hydrochlorothiazide | 26 | $226 | $9 |
| Amlodipine Besylate | 18 | $211 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $197 | $14 |
| Lisinopril | 17 | $172 | $10 |
| Atenolol | 12 | $160 | $13 |
| Clonazepam | 13 | $97 | $7 |
2015: 15 drugs
| Levothyroxine | 56 | $1,455 | $26 |
| Atorvastatin | 51 | $1,233 | $24 |
| Metoprolol | 15 | $880 | $59 |
| Simvastatin | 78 | $786 | $10 |
| Synthroid | 18 | $666 | $37 |
| Hydrochlorothiazide | 23 | $285 | $12 |
| Zolpidem | 12 | $248 | $21 |
| Losartan | 18 | $180 | $10 |
| Fluticasone Propionate | 12 | $140 | $12 |
| Amlodipine Besylate | 14 | $136 | $10 |
| Losartan-Hydrochlorothiazide | 11 | $127 | $12 |
| Atenolol | 12 | $126 | $10 |
| Lisinopril | 16 | $119 | $7 |
| Lisinopril-Hydrochlorothiazide | 12 | $116 | $10 |
| Clonazepam | 13 | $54 | $4 |
2014: 14 drugs
| Prempro | 12 | $3,575 | $298 |
| Levothyroxine | 49 | $1,339 | $27 |
| Metoprolol | 17 | $1,264 | $74 |
| Atorvastatin | 54 | $1,139 | $21 |
| Simvastatin | 76 | $907 | $12 |
| Synthroid | 12 | $402 | $33 |
| Fluticasone Propionate | 15 | $301 | $20 |
| Hydrochlorothiazide | 23 | $281 | $12 |
| Zolpidem | 13 | $233 | $18 |
| Losartan | 16 | $170 | $11 |
| Lisinopril-Hydrochlorothiazide | 14 | $150 | $11 |
| Amlodipine Besylate | 14 | $136 | $10 |
| Lisinopril | 16 | $129 | $8 |
| Alprazolam | 23 | $79 | $3 |
2013: 11 drugs
| Atorvastatin | 41 | $1,465 | $36 |
| Simvastatin | 67 | $1,122 | $17 |
| Levothyroxine | 63 | $1,011 | $16 |
| Losartan-Hydrochlorothiazide | 18 | $409 | $23 |
| Lisinopril-Hydrochlorothiazide | 16 | $330 | $21 |
| Synthroid | 14 | $329 | $23 |
| Hydrochlorothiazide | 27 | $244 | $9 |
| Lisinopril | 21 | $193 | $9 |
| Amlodipine Besylate | 14 | $191 | $14 |
| Fluoxetine | 11 | $131 | $12 |
| Zolpidem | 14 | $112 | $8 |
Money from drug and device companies
$272 in 2025
| 2025 | 9 | 12 | None | $272 |
| 2024 | 6 | 25 | None | $450 |
| 2023 | 6 | 9 | None | $202 |
| 2022 | 2 | 3 | None | $66 |
| 2021 | 3 | 5 | None | $83 |
| 2020 | 7 | 10 | None | $191 |
| 2019 | 15 | 32 | None | $631 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $66 | 3 payments
|
| Pfizer | Prevnar 20 | $44 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $27 | 1 payment
|
| Lilly USA | Kisunla | $27 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $25 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $23 | 1 payment
|
See all 12 published payments
| Pfizer | Meals · 2025-11-13 | Prevnar 20 | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-10 | None | $18 |
| Abbvie | Meals · 2025-11-03 | Ubrelvy | $19 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-29 | Caplyta | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-08 | Kerendia | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-05 | Farxiga | $27 |
| Exact Sciences | Meals · 2025-08-27 | The Cologuard Plus Collection Kit | $20 |
| Pfizer | Meals · 2025-07-28 | Prevnar 20 | $24 |
| Lilly USA | Meals · 2025-07-17 | Kisunla | $27 |
| Sumitomo Pharma America | Meals · 2025-07-11 | Gemtesa | $21 |
| Abbvie | Meals · 2025-03-29 | Qulipta | $32 |
| Abbvie | Meals · 2025-02-06 | Qulipta | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $450
| Abbvie | Qulipta | $322 | 18 payments
|
| Pfizer | Prevnar 20 | $38 | 2 payments
|
| Lilly USA | Mounjaro | $35 | 2 payments
|
| Astellas Pharma US | Veozah | $22 | 1 payment
|
| Novo Nordisk | Rybelsus | $16 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
2023: $202
| AbbVie | Qulipta | $78 | 3 payments
|
| Pfizer | Comirnaty | $39 | 2 payments
|
| GlaxoSmithKline | Arexvy | $25 | 1 payment
|
| Hikma Pharmaceuticals USA | Ryaltris | $23 | 1 payment
|
| Sanofi Pasteur | Flublok Quadrivalent Northern Hemisphere | $20 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $18 | 1 payment
|
2022: $66
| GlaxoSmithKline | Trelegy Ellipta | $53 | 2 payments
|
| Abbvie | Ubrelvy | $13 | 1 payment
|
2021: $83
| Pfizer | Cologuard Dna Capture Reagents | $55 | 3 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $14 | 1 payment
|
| Novo Nordisk | Rybelsus | $14 | 1 payment
|
2020: $191
| Lilly USA | Emgality | $57 | 3 payments
|
| Pfizer | Eucrisa | $39 | 2 payments
|
| Allergan | Ubrelvy | $22 | 1 payment
|
| Astellas Pharma US | Vesicare | $22 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $21 | 1 payment
|
| Gilead Sciences | Descovy | $18 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $12 | 1 payment
|
2019: $631
| TherapeuticsMD | Imvexxy | $94 | 5 payments
|
| Kowa Pharmaceuticals America | Livalo | $73 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $67 | 3 payments
|
| Teva Pharmaceuticals USA | Ajovy | $56 | 2 payments
|
| Lilly USA | Emgality | $55 | 3 payments
|
| Arbor Pharmaceuticals | Horizant | $42 | 2 payments
|
| GlaxoSmithKline | Shingrix | $39 | 2 payments
|
| Pfizer | Eucrisa | $37 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $35 | 2 payments
|
| Allergan | Vraylar | $31 | 2 payments
|
| Merck Sharp & Dohme | Pneumovax 23 | $29 | 2 payments
|
| Gilead Sciences | Truvada | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
| AMAG Pharmaceuticals | Makena | $15 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $14 | 1 payment
|
Professional record
- NPI
- 1386754133
- Licence
- CA A068218
- Trained
- University of California, Geffen School of Medicine, 1997
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 360 Dardanelli Ln, 2e, Los Gatos, CA, 95032
- NPI first listed
- 2006-08-30
- NPI last updated
- 2022-12-07
- NPI record certified
- 2022-12-07
This is when the NPI record was last certified, not a medical board exam.